Review of GLP-1 drug emerging therapeutic potential in psoriasis management covers anti-inflammatory mechanisms that may benefit this autoimmune skin disease.
Key findingReview of GLP-1 drug emerging therapeutic potential in psoriasis management covers anti-inflammatory
What the researchers found
Review of GLP-1 drug emerging therapeutic potential in psoriasis management covers anti-inflammatory mechanisms that may benefit this autoimmune skin disease.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
GLP-1 receptor agonists: emerging therapeutic potential in psoriasis management - current evidence and future outlook.
European journal of clinical pharmacology, 81(11), 1569-1581
Citation
Atiquzzaman, Nabiha; Razdolsky, Nicole; Parmar, Mayur S. (2025). GLP-1 receptor agonists: emerging therapeutic potential in psoriasis management - current evidence and future outlook.. European journal of clinical pharmacology, 81(11), 1569-1581. https://doi.org/10.1007/s00228-025-03898-4